Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NHS on track to make £358 million in drug savings

December 23, 2011 Sales and Marketing DoH, NHS, QIPP

The NHS in England is set to make £358 million in savings from drugs over the financial year, according to …
News

RSA makes three new appointments

December 22, 2011 Business Services, Medical Communications, Sales and Marketing rsa

Life sciences recruitment firm RSA has announced three new appointments to its UK office. Dr David Jay joins RSA UK …
Appointment

FDA accepts Pfizer’s arthritis pill for review

December 22, 2011 Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

The FDA has accepted Pfizer’s novel arthritis pill tofacitinib for review, and could be on the US market next year. …
News

GSK sells off over-the-counter brands

December 22, 2011 Sales and Marketing GSK, OTC

GlaxoSmithKline has offloaded a number of OTC consumer health brands in North America for £426 million in cash.  Flagged up …
News

AstraZeneca takes option on new diabetes candidates

December 21, 2011 Sales and Marketing AstraZeneca, diabetes

AstraZeneca and Prosidion, a subsidiary of Astellas have signed a deal giving AstraZeneca an exclusive option to acquire two diabetes …
News

Caudex Medical makes two senior appointments

December 21, 2011 Business Services, Medical Communications, Sales and Marketing Andy Bowman, Caudex Medical, Gary Burd

Andy Bowman and Gary Burd have been appointed to senior positions within the medical communications firm Caudex Medical.  Bowman has …
Appointment

FDA to probe Gilenya patient death

December 21, 2011 Sales and Marketing FDA, Novartis, gilenya

The FDA is investigating Novartis’s new multiple sclerosis treatment Gilenya after a patient died within hours of taking the drug. …
News

Xarelto gains new licences in UK

December 20, 2011 Sales and Marketing

Bayer’s anticoagulant pill Xarelto has gained two new lucrative licences, and is now available in the UK to prevent stroke …
News

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011 Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …
News

AstraZeneca posts drug failures, takes $382m hit

December 20, 2011 Research and Development, Sales and Marketing AstraZeneca, depression, ovarian cancer

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …
News

Brilique recommended for use by Germany’s pricing watchdog

December 19, 2011 Sales and Marketing AstraZeneca, Brilique, Plavix

Germany’s new pricing committee has said that AstraZeneca’s Brilique is a cost effective treatment for patients with a certain heart …
News

Ex-EMA chief ran consultancy firm whilst still in office

December 19, 2011 Sales and Marketing EMA, Lonngren, NDA

The former head of the European Medicines Agency Thomas Lonngren set up his own consultancy business to advise pharma whilst …
News

Key product launches of 2011

December 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products

 Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …
Feature

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …
Appointment

Sanofi sheds dermatology unit for $423 million

December 19, 2011 Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi

Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million.  The unit has been sold to …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026